Associations Between Physical Pain, Pain Management, and Frequency of Nonmedical Prescription Opioid Use Among Young Adults: A Sex-specific Analysis

Journal of Addiction Medicine

Volumn 11, Issue 4, 2017, Pages 266-272

  Evans, Tristan I ^a   Liebling, Elliott J ^a   Green, Traci C ^a,b,c   Hadland, Scott E ^d,e,f   Clark, Melissa A ^a,g   Marshall, Brandon D L ^a  

^a BROWN UNIVERSITY   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c BROWN UNIVERSITY   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

nonmedical prescription opioid use; pain management; physical pain; young adult

Indexed keywords

NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ADULT; AGE; ANALGESIA; ARTICLE; BENZODIAZEPINE DEPENDENCE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DRUG MISUSE; FEMALE; GENDER; HARM REDUCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NONMEDICAL PRESCRIPTION OPIOID USE; OPIATE ADDICTION; PAIN; PAIN SEVERITY; PHYSICAL PAIN; PILOT STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; RHODE ISLAND; RISK FACTOR; SELF MEDICATION; YOUNG ADULT;

EID: 85026854658     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0000000000000318     Document Type: Article

References (39)

1. Ahern J, Stuber J, Galea S. Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend 2007;88:188-196.
2. Alford DP, Compton P, Samet JH. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med 2006;144:127-134.
3. Barry DT, Irwin KS, Jones ES, et al. Opioids, chronic pain, and addiction in primary care. J Pain 2010;11:1442-1450.
4. Bartley EJ, Fillingim RB. Sex differences in pain: a brief review of clinical and experimental findings. Br J Anaesth 2013;111:52-58.
5. Becker WC, Sullivan LE, Tetrault JM, et al. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend 2008;94: 38-47.
6. Bush K, Kivlahan DR, McDonell MB, et al. The AUDI Talcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998;158:1789-1795.
7. Butler SF, Budman SH, Fanciullo GJ, et al. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy. Clin J Pain 2010;26:770-776.
8. Butler SF, Budman SH, Fernandez K, et al. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004;112:65-75.
9. Centers for Disease Control and Prevention. CDC grand rounds: prescription drug overdoses: a U.S. epidemic. MMWR Morb Mortal Wkly Rep 2012;61:10-13.
10. Chou R, Fanciullo GJ, Fine PG, et al. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009;10:131-146.
11. Cranford JA, McCabe SE, Boyd CJ. Adolescents' nonmedical use and excessive medical use of prescription medications and the identification of substance use subgroups. Addict Behav 2013;38:2768-2771.
12. Dowden S. Considerations of non-medical use of prescription opioids (NMUPO) in pediatric pain management. Pediatric Pain Letter 2014;16: 15-21.
13. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain: United States, 2016. JAMA 2016;315:1624-1645.
14. Fibbi M, Silva K, Johnson K, et al. Denial of prescription opioids among young adults with histories of opioid misuse. Pain Med 2012;13: 1040-1048.
15. Green TC, Grimes Serrano JM, Licari A, et al. Women who abuse prescription opioids: findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database. Drug Alcohol Depend 2009;103: 65-73.
16. Green TC, Zaller N, Palacios WR, et al. Law enforcement attitudes toward overdose prevention and response. Drug Alcohol Depend 2013;133: 677-684.
17. Harrell FJ. Regression Modeling Strategies. Cham, Switzerland: Springer International Publishing; 2015.
18. Jamison RN, Kauffman J, Katz NP. Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage 2000;19:53-62.
19. Jones T, Moore T. Preliminary data on a new opioid risk assessment measure: the Brief Risk Interview. J Opioid Manag 2013;9:19-27.
20. King SA. Iatrogenic opioid use disorder: an issue ignored. Psychiatric Times 2014;31:32G-132G.
21. Krebs EE, Lorenz KA, Bair MJ, et al. Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med 2009;24:733-738.
22. Lessenger JE, Feinberg SD. Abuse of prescription and over-the-counter medications. J Am Board Fam Med 2008;21:45-54.
23. Lima VD, Harrigan R, Murray M, et al. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals. AIDS 2008;22:2371-2380.
24. Pettes T, Kerr T, Voon P, et al. Depression and sexual risk behaviours among people who inject drugs: a gender-based analysis. Sex Health 2015;12: 224-230.
25. Rosenblum A, Joseph H, Fong C, et al. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA 2003;289:2370-2378.
26. Rosenblum A, Marsch LA, Joseph H, et al. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol 2008;16:405-416.
27. Rudd RA, Seth P, David F, et al. Increases in drug and opioid-involved overdose deaths: United States, 2010-2015. MMWR Morb Mortal Wkly Rep 2016;65:1445-1452.
28. Rupp T, Delaney KA. Inadequate analgesia in emergency medicine. Ann Emerg Med 2004;43:494-503.
29. Rutkow L, Turner L, Lucas E, et al. Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access. Health Aff (Millwood) 2015;34:484-492.
30. Savage SR, Kirsh KL, Passik SD. Challenges in using opioids to treat pain in persons with substance use disorders. Addict Sci Clin Pract 2008;4: 4-25.
31. Silva K, Schrager SM, Kecojevic A, et al. Factors associated with history of non-fatal overdose among young nonmedical users of prescription drugs. Drug Alcohol Depend 2013;128:104-110.
32. Sterling S, Weisner C, Hinman A, et al. Access to treatment for adolescents with substance use and co-occurring disorders: challenges and opportunities. J Am Acad Child Adolesc Psychiatry 2010;49:637-646, quiz 725-636.
33. Ti L, Voon P, Dobrer S, et al. Denial of pain medication by health care providers predicts in-hospital illicit drug use among individuals who use illicit drugs. Pain Res Manag 2015;20:84-88.
34. Tobin DG, Andrews R, Becker WC. Prescribing opioids in primary care: Safely starting, monitoring, and stopping. Cleve Clin J Med 2016;83: 207-215.
35. Twillman RK. Mental disorders in chronic pain patients. J Pain Palliat Care Pharmacother 2007;21:13-19.
36. Voon P, Kerr T. "Nonmedical" prescription opioid use in North America: a call for priority action. Subst Abuse Treat Prev Policy 2013;8:39.
37. Voon P, Callon C, Nguyen P, et al. Denial of prescription analgesia among people who inject drugs in a Canadian setting. Drug Alcohol Rev 2015;34:221-228.
38. Voon P, Hayashi K, Milloy MJ, et al. Pain among high-risk patients on methadone maintenance treatment. J Pain 2015;16:887-894.
39. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159:702-706.